Quick Answer
Dianthus Therapeutics, Inc. /DE/ reported Cash And Cash Equivalents At Carrying Value of $51.09 million for the year ending 2025.
- Dianthus Therapeutics, Inc. /DE/ showed an increase of +124.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Dianthus Therapeutics, Inc. /DE/'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2017 to 2025), Dianthus Therapeutics, Inc. /DE/'s Cash And Cash Equivalents At Carrying Value has declined by 0.6%.
- Historical annual values: Fiscal year 2025: $51.09 million | Fiscal year 2024: $22.79 million | Fiscal year 2023: $132.33 million | Fiscal year 2022: $15.37 million | Fiscal year 2021: $131.65 million | Fiscal year 2020: $58.15 million | Fiscal year 2019: $65.07 million | Fiscal year 2018: $58.35 million | Fiscal year 2017: $51.40 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: